Replies to post #154992 on Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

How is it different?

[MinnieM]

Other than dollar amounts, is there something about their contract that is different from the deals Aspire has had with Cellceutix?

Have a great weekend all.









In Reply to 'septmike09'
Now why can't CTIX get this kind of deal with Aspire? Stock exploded when this deal was announced.

http://phx.corporate-ir.net/phoenix.zhtml?c=253723&p=irol-newsArticle&ID=2176448

[BonelessCat]

CTIX, Leo, did get the same deal. I will hazard to guess in fact it is identical, or very close to it. The article said prevailing market prices, but does not mention the formula for determining the actual payment for prevailing prices. I'll be looking for that additional info once I'm off my iPhone.

[chico2663]

What am I missing. The stock is selling for 1.94. It has a high of 5.02 for the year. A low of 1.19. Please don't let them settle for this. i am hoping to double or get 10 times my investment

[vip1999]

when we get funded, the stock will move, but that is not what we are here for, right?

Ph3 of B starts, hopefully with a partnership, if not, not a big deal. I think we will have funding in any case go through 2018. Just my opinion.

[frrol]

Share price appreciation doesn't happen in a vacuum. Funding was clearly a concern for that company and its market cap was apparently low in the market's view (ie, share price was very attractive).

I think Cellceutix may be viewed viewed as a bit slow and erratic in its clinical programs. I disagree, but I only get one vote in the market :-) Anyway its market cap is substantial compared to some other young biotechs, commensurate with its progress, though I think it should be higher. But then again, that's why I hold so many shares.